Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
79.38 +4.90  +6.58% NASDAQ Apr 16, 8:00PM BATS Real time Currency in USD

Synageva BioPharma Price to Book Value:

5.707 for April 16, 2014

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Price to Book Value Chart

Export Data
Save Image

Synageva BioPharma Historical Price to Book Value Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
April 16, 2014 5.707
April 15, 2014 5.355
April 14, 2014 5.514
April 11, 2014 5.658
April 10, 2014 5.747
April 9, 2014 6.096
April 8, 2014 5.663
April 7, 2014 5.510
April 4, 2014 5.26
April 3, 2014 5.548
April 2, 2014 5.788
April 1, 2014 5.992
March 31, 2014 5.965
March 28, 2014 5.426
March 27, 2014 5.690
March 26, 2014 5.657
March 25, 2014 5.793
March 24, 2014 5.826
March 21, 2014 6.519
March 20, 2014 7.202
March 19, 2014 7.197
March 18, 2014 7.274
March 17, 2014 7.002
March 14, 2014 6.764
March 13, 2014 6.813
   
March 12, 2014 7.160
March 11, 2014 7.041
March 10, 2014 7.036
March 7, 2014 7.078
March 6, 2014 7.067
March 5, 2014 7.603
March 4, 2014 7.476
March 3, 2014 7.287
Feb. 28, 2014 8.244
Feb. 27, 2014 8.514
Feb. 26, 2014 8.296
Feb. 25, 2014 8.339
Feb. 24, 2014 8.054
Feb. 21, 2014 7.903
Feb. 20, 2014 7.786
Feb. 19, 2014 7.632
Feb. 18, 2014 7.265
Feb. 14, 2014 7.156
Feb. 13, 2014 7.093
Feb. 12, 2014 7.116
Feb. 11, 2014 7.022
Feb. 10, 2014 6.942
Feb. 7, 2014 6.487
Feb. 6, 2014 6.101
Feb. 5, 2014 6.124

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Get data for
Advertisement

GEVA Price to Book Value Benchmarks

Companies
Alexion Pharmaceuticals 12.32
Actelion 6.776
Gilead Sciences 9.374

GEVA Price to Book Value Range, Past 5 Years

Minimum 0.7259 Sep 12 2011
Maximum 10.47 Mar 27 2012
Average 3.653
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.